Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 433–456 of 494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fish OIl Clear all

Conditions: Endothelial Dysfunction, Insulin Resistance, Metabolic Syndrome, Peripheral Arterial Disease
Interventions: Fish Oil (Omega-3 Fatty Acids); Dietary Supplement
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 50 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: IgA Nephropathy
Interventions: Mycophenolate Mofetil (MMF), MMF Placebo, ACEi, FOS; Drug
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: 7 Years to 70 Years
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2010
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: IgA Glomerulonephritis
Interventions: omega-3 fatty acids, prednisone, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: Up to 40 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2007
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Inflammation
Interventions: Omega-3 fish oil, Losartan, Corn Oil (Fish oil Placebo), Cellulose Based (Losartan Placebo); Dietary Supplement · Drug · Other
Lead sponsor: University of Florida; Other
Eligibility: 70 Years and older
Enrollment: 289 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 5
States / cities: Gainesville, Florida • Chicago, Illinois • Boston, Massachusetts + 2 more

Conditions: Healthy, Dietary Supplement
Interventions: Ozone, Fish Oil, Olive Oil; Drug · Dietary Supplement
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 35 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Infant Development
Interventions: Docosahexaenoic acid (DHA) and arachidonic acid (ARA), Corn oil placebo; Dietary Supplement
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 351 Days to 379 Days
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Atrial Fibrillation
Interventions: Omega Three Polyunsaturated fatty acids; Drug
Lead sponsor: Chirag Sandesara; Other
Eligibility: 18 Years to 85 Years
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Non-Alcoholic Fatty Liver Disease, Obesity
Interventions: Moderately carbohydrate-restricted diet, Fat-restricted diet; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 10 Years to 17 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Schizophrenia
Interventions: Olanzapine, Omega 3, Vitamin E+C; Drug
Lead sponsor: Augusta University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2005
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Rheumatoid Arthritis (RA), Crohn's Disease (CD), Ulcerative Colitis (UC)
Interventions: Ketogenic diet, Carnivore (Lion) Diet; Behavioral
Lead sponsor: Fuller Research Foundation; Other
Eligibility: 18 Years to 64 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Liver Disease
Interventions: Intravenous Lipid Emulsion Comprised of Fish Oil; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 14 Days to 24 Months
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: T2DM (Type 2 Diabetes Mellitus)
Interventions: ORMD-0801, Placebo; Drug · Other
Lead sponsor: Oramed, Ltd.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 346 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Cholestasis, Liver Disease
Interventions: Enteral fish oil, Ursodeoxycholic Acid, Placebo; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 14 Days to 24 Months
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Sarcopenia
Interventions: Omega-3 fatty acids; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Type2 Diabetes Mellitus, Hypertension, PreDiabetes, Overweight and Obesity
Interventions: DASH diet, Very low carbohydrate, ketogenic diet, Extras; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years to 70 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Healthy
Interventions: omega-3 fatty acids, corn oil; Dietary Supplement
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 85 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Heart Failure
Interventions: Dietary Approaches to Stop Hypertension Diet; Other
Lead sponsor: University of Georgia; Other
Eligibility: 65 Years to 110 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis
Interventions: ORMD-0801 (Insulin) capsule 8 mg BD, Placebo; Drug · Other
Lead sponsor: Oramed, Ltd.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Tustin, California

Conditions: Cholesterol, Triglycerides, Omega-3, Eicosapentaenoic Acid
Interventions: AlmegaPL (FDA NDIN # 826); Dietary Supplement
Lead sponsor: Qualitas Health; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 2
States / cities: Tempe, Arizona • Houston, Texas

Conditions: Dyslipidemia
Interventions: Alirocumab, Statins, Ezetimibe, Fenofibrate, Nicotinic acid, Omega-3 fatty acids, Antihyperglycemic Drug; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 413 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 57
States / cities: Little Rock, Arkansas • Fresno, California • Huntington Beach, California + 51 more

Conditions: Heart Failure
Interventions: LOVAZA (Omega-3), Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Inflammation
Interventions: Omega-3 fatty acid, Placebo; Dietary Supplement
Lead sponsor: University of Memphis; Other
Eligibility: 60 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Traumatic Brain Injury (TBI), Chronic Traumatic Encephalopathy (CTE)
Interventions: Fish Oil (DPA+EPA 2:1 ratio) Capsules, High Oleic Safflower Oil Capsules; Dietary Supplement
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 25 Years · Male only
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Short Bowel Syndrome, Intestinal Fistula, Crohn Disease, Intestinal Obstruction
Interventions: SMOFLipid, Intralipid; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy

The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study

Efficacy of Fish Oil or Olive Oil Supplementation on the Health Effects of Ozone Exposure in Healthy Young Subjects

Effect of Long-Chain Polyunsaturated Fatty Acid Supplementation on Toddler Cognition

Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery

Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents

Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids

Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis

Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver Injury

A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants

Omega-3 Fatty Acids to Combat Sarcopenia

The MHERO Study (Michigan's Hypertension, Diabetes, and Obesity Education Research Online)

Omega-3 Fatty Acids and Muscle Protein Synthesis

Effect of DASH on HF Outcomes Heart Failure Status in Older Adults (DASH HF)

A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

AlmegaPL CV Health Open Label Study

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure

Omega-3 Fatty Acid Supplementation in Older Adults

The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes

Intralipid Versus SMOFlipid in HPN Patients